Lyon wrote:It's a forerunner of Tovaxin because it regards the same Dr Zhang who developed Tovaxin
I've often wondered about the T-cell vaccination approach. Given the research showing that there's more going on beside just de-myelination (i.e. nerve cell death), and that B cells may somehow be involved, is targeting myelin reactive T cells enough? Especially considering that treatments like Campath, which target both T cells and B cells, show good results. I wonder if the researchers investigting the T-cell vaccination considered this, or if they just focused on the de-myelination aspect of MS.